Key result
The wild-type negative regulator of splicing (NRS) assembled an aberrant, stalled 50S spliceosome complex that sequesters the 3' splice site and prevents interaction with the authentic 5' splice site.
The retroviral negative regulator of splicing (NRS) suppresses splicing by assembling an aberrant, stalled spliceosome that sequesters the 3' splice site.
No takes yet. Share an insight, caveat, or question.
No immediate clinical implications; leaves open mechanistic studies of stalled spliceosomes for therapeutic targeting.
Giles et al. (2005) studied Retroviral replication. Wild-type NRS-Ad3' transcript vs. Mutant NRS-Ad3' RNA was evaluated on Spliceosome complex formation and splicing capability. The wild-type negative regulator of splicing (NRS) assembled an aberrant, stalled 50S spliceosome complex that sequesters the 3' splice site and prevents interaction with the authentic 5' splice site.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: